title: Advanced ovarian carcinoma following bilateral uterine artery embolization: a case report.
abstract: BACKGROUND
  Bilateral uterine artery embolization has become an accepted therapeutic modality in the management of patients with symptomatic uterine leiomyomata. Complications of bilateral uterine artery embolization, including rare cases of malignancies, have been reported following this procedure.
  
  
  METHODS
  We present a 46-year-old woman, gravida 3, para 1, who was treated with bilateral uterine artery embolization for symptomatic uterine leiomyomata following pelvic sonography and magnetic resonance imaging, which depicted bilateral normal adnexa. Nine months after the procedure she was diagnosed with stage III ovarian carcinoma.
  
  
  CONCLUSIONS
  Patients undergoing bilateral uterine artery embolization should be informed of the possibility of preexisting or potential subsequent development of ovarian carcinoma, reflecting the lack of an effective screening method for this disease.
authors.affiliation: Division of Gynecologic Oncology, the Department of Obstetrics and Gynecology, State University of New York, Downstate Medical Center, 445 Lenox Road, Box 24, Brooklyn, NY 11203-2098, USA.
authors.forename: Allison
authors.initials: A
authors.lastname: Wagreich
authors.forename: Ghadir
authors.initials: G
authors.lastname: Salame
authors.forename: Yi-Chun
authors.initials: YC
authors.lastname: Lee
authors.forename: Ovadia
authors.initials: O
authors.lastname: Abulafia
mesh_terms: D002291:Carcinoma, Papillary / Q000175:diagnosis / Q000188:drug therapy / Q000601:surgery; D002945:Cisplatin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007889:Leiomyoma / Q000628:therapy*; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000175:diagnosis* / Q000188:drug therapy / Q000601:surgery; D017239:Paclitaxel / Q000008:administration & dosage; D055357:Uterine Artery Embolization / Q000009:adverse effects*; D014594:Uterine Neoplasms / Q000628:therapy*
chemical_list: D017239:Paclitaxel; D002945:Cisplatin